SARS-CoV-2 evolution during treatment of chronic infection

SARS-CoV-2 Spike protein is critical for virus infection via engagement of ACE2(1), and is a major antibody target. Here we report chronic SARS-CoV-2 with reduced sensitivity to neutralising antibodies in an immune suppressed individual treated with convalescent plasma, generating whole genome ultra...

Descripción completa

Detalles Bibliográficos
Autores principales: Kemp, Steven A, Collier, Dami A, Datir, Rawlings P, Ferreira, Isabella ATM, Gayed, Salma, Jahun, Aminu, Hosmillo, Myra, Rees-Spear, Chloe, Mlcochova, Petra, Lumb, Ines Ushiro, Roberts, David J, Chandra, Anita, Temperton, Nigel, Sharrocks, Katherine, Blane, Elizabeth, Modis, Yorgo, Leigh, Kendra, Briggs, John, van Gils, Marit, Smith, Kenneth GC, Bradley, John R, Smith, Chris, Doffinger, Rainer, Ceron-Gutierrez, Lourdes, Barcenas-Morales, Gabriela, Pollock, David D, Goldstein, Richard A, Smielewska, Anna, Skittrall, Jordan P, Gouliouris, Theodore, Goodfellow, Ian G, Gkrania-Klotsas, Effrossyni, Illingworth, Christopher JR, McCoy, Laura E, Gupta, Ravindra K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610568/
https://www.ncbi.nlm.nih.gov/pubmed/33545711
http://dx.doi.org/10.1038/s41586-021-03291-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610568/
https://www.ncbi.nlm.nih.gov/pubmed/33545711
http://dx.doi.org/10.1038/s41586-021-03291-y

Ejemplares similares